Showing results (1981-1990 of 3,796) with videos related to
Sort By:
Pageof 380
Oncoimmunology|December 14, 2020
Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trialHanren Dai, Chuan Tong, Daiwei Shi, et al.Oncoimmunology|June 16, 2022
Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancerJia Bo Zheng, Chau Wei Wong, Jia Liu, et al.Oncoimmunology|June 9, 2021
Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancerLin Zhou, Bin Xu, Yushan Liu, et al.Oncoimmunology|June 9, 2021
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitorsFrançois Bertucci, Laurys Boudin, Pascal Finetti, et al.Oncoimmunology|June 23, 2017
Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensorsKeisuke Fujii, Yoshihiro Miyahara, Naozumi Harada, et al.Oncoimmunology|June 23, 2017
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapyMasaki Terabe, Faith C Robertson, Katharine Clark, et al.Oncoimmunology|June 23, 2017
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cellsIrena Adkins, Lenka Sadilkova, Nada Hradilova, et al.Oncoimmunology|June 23, 2017
Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytesQian Zhu, Mu-Yan Cai, Chang-Long Chen, et al.Oncoimmunology|February 10, 2022
Immune sunrise: from the immunome to the cancer immune landscapeGabriela Bindea, Bernhard Mlecnik, Jérôme GalonOncoimmunology|October 7, 2021
Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b studyWencheng Zhang, Cihui Yan, Tian Zhang, et al.Pageof 380